Description
Release Date: 11/17/2011
Termination Date: 11/17/2012
Acknowledgement
Contemporary Multidisciplinary Cardiovascular Medicine is supported in part by an educational grant from AstraZeneca.
Program:
Please view the video presentation by following the link below. Windows Media is required for viewing. If you have any questions regarding this presentation you may use the "Contact Us" Tab to submit an email. To earn CME credit for your participation in this activity, you may access the post test following the completion of viewing the video.
Planning Committee and Planning Committee Disclosures:
The following planning committee members have no significant financial interests or relationships with commercial interests to disclose. Their educational unit does not have a financial interest or affiliation with an organization that may receive direct benefit from the subject of the proposed CME activity and they will not be personally compensated for their roles in the planning or execution of this proposed CME activity by an organization other than The Ohio State University.
Laxmi Mehta, MD, F.A.C.C.
Tom Ryan, MD
William T. Abraham, MD, FACP, FACC, FAHA, discloses he has the following relevant financial interests or relationships with commercial interests. Advisory Board Membership: ARCA BioPharm, BioEnergy, Biotronik, Capricor, Cardiac Concepts, CardioKine, CardioKinetix Inc., CardioMEMS, Edwards Lifesciences, Medtronic Inc., National Institutes of Health, Paracor Inc, St. Jude Medical, Sunshine Heart; Honorarium Recipient: Medtronic Inc., Respironics, St. Jude Medical; Consultant/Speaker Bureau: Medtronic Inc., Respironics, St. Jude Medical. Grants/Research Support: National Institutes of Health, Medtronic Inc., Paracor Inc., St. Jude Medical; Editorial Board Involvement: Congestive Heart Failure, Current Cardiology Reviews, Current Heart Failure Reports, Expert Review of Cardiovascular Therapy, European Heart Journal,
Journal Watch Cardiology, PACE – Pacing and Clinical Electrophysiology, The American Heart Hospital Journal, The Journal of Heart Failure. His educational unit does not have a financial interest or affiliation with an organization that may receive direct benefit from the subject of the proposed CME activity and he will not be personally compensated for his role in the planning or execution of this proposed CME activity by an organization other than The Ohio State University.
Speaker and Speaker Disclosures:
The following speakers for this educational activity disclose that they have no significant financial interests or relationships with commercial interests to disclose. His presentation will not include any discussion of unapproved or “off label” usage of a commercial product or device.
Quinn Capers, MD
Michael A. Blazing, MD, discloses he has the following relevant financial interests or relationships with commercial interests. Advisory Board Membership: Merck; Consultant/Speaker Bureau: Merck, CSL Behring; Grants/Research Support: Merck, CSL. His presentation will not include any discussion of unapproved or “off label” usage of a commercial product or device.
Jeffrey Pompa, MD, discloses he has the following relevant financial interests or relationships with commercial interests. Advisory Board Membership: Boston Scientific, Cordis; Grants/Research Support: Medtronic, Boston Scientific, Cordis, Ev3, Abott. His presentation will include discussion of unapproved or “off label” usage of a commercial product or device.
Dates and Times
End Date: 11/17/2012
Objectives
1. Discuss the current and future stents in the treatment of CAD. 2. Discuss the use of anti-platelet therapy following coronary artery stent placement. 3. Discuss the management of CAD in the high-risk patient. 4. Discuss the utilization of statins in the hyperlipidemic patient.Internet Enduring Material Files
Speakers
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.